[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355735-105":59,"doc-detail-355735-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","precision-prevention-and-progress-charting-two-decades-of-change-in-gynaecological-oncology-a-narrative-review","Precision, prevention and progress: charting two decades of change in gynaecological oncology - a narrative review","","A narrative review examines how gynaecological oncology has evolved over the past 25 years through prevention, molecular therapeutics, and surgical innovation. The review synthesizes landmark publications and guideline updates from 2000 to 2025, focusing on cervical, ovarian, endometrial, vulvar, and vaginal cancers. Key themes include HPV vaccination impact, shifts toward less radical and function-preserving surgery, precision-driven molecular classification, and integration of targeted and immune therapies to improve outcomes across disease stages.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/precision-prevention-and-progress-charting-two-decades-of-change-in-gynaecological-oncology-a-narrative-review/355735/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/precision-prevention-and-progress-charting-two-decades-of-change-in-gynaecological-oncology-a-narrative-review/355735.png","ImageObject",300,407,{"name":92,"@type":93},"Terk","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What time span and evidence sources does the review cover?","Question",{"text":112,"@type":113},"The review is a structured narrative review of landmark publications and guideline updates published between 2000 and 2025.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How has cervical cancer management changed according to the review?",{"text":117,"@type":113},"Population-level HPV vaccination reduced incidence, and trials such as LACC and SHAPE drove a move back toward open and less radical surgery, alongside sentinel node biopsy and improved locally advanced survival with combined chemoradiotherapy plus immunotherapy.",{"name":119,"@type":110,"acceptedAnswer":120},"What overarching model defines modern gynaecological oncology in the conclusions?",{"text":121,"@type":113},"Modern gynaecological oncology is defined by prevention, precision, and personalisation, integrating molecular insight, function-preserving surgery, and multidisciplinary collaboration for patient-centred care.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},355735,1790746873,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099525198933,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Review Article  \nPrecision, prevention and progress: charting two decades of change in gynaecological oncology—a narrative review  \nSabina Ioana Nistor1\\#^, Ruyu Shao2\\#^, Jacopo Conforti1,3^, Francis Gardner1, Federico Ferrari3^, Lamiese Ismail4^, Xiaoyu Niu5^, Desheng Yao2^, Hooman Soleymani majd1,6^  \n1Department of Gynaecological Oncology, Churchill Hospital, Oxford University Hospitals National Health Service (NHS) Foundation Trust, Oxford, UK; 2Department of Gynaecological Oncology, Guangxi Medical University Cancer Hospital, Nanning, China; 3Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy; 4Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Oxford University Hospitals National Health Service (NHS) Foundation Trust, Oxford, UK; 5Obstetrics and Gynaecology Department, The West China Second University Hospital of Sichuan University, Chengdu, China; 6Nuffield Department of Women’s and Reproductive Health, University of Oxford, Oxford, UK Contributions: (I) Conception and design: SI Nistor, R Shao, H Soleymani majd; (II) Administrative support: None; (III) Provision of study materials or patients: None; (IV) Collection and assembly of data: SI Nistor, R Shao, J Conforti; (V) Data analysis and interpretation: SI Nistor, R Shao, HSoleymani majd; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.  \n\\#These authors contributed equally to this work as co-first authors.  \nCorrespondence to: Hooman Soleymani majd, MD. Department of Gynaecology Oncology, Churchill Hospital, Oxford University Hospitals National Health Service (NHS) Foundation Trust, Old Rd, Headington, Oxford OX3 7LE, UK; Nuffield Department of Women’s and Reproductive Health, University of Oxford, Oxford, [UK. Email: hooman.soleymanimajd@msd.ox.ac.uk](UK. Email: hooman.soleymanimajd@msd.ox.ac.uk).  \nBackground and Objective: The field of Gynaecological Oncology (GO) has undergone a paradigm shift over recent decades, shaped by advancements in prevention, molecular therapeutics, and surgical innovation. We explore how the management of gynaecological malignancies has transformed in the past  \n25 years.  \nMethods: A structured narrative review of landmark publications and guideline updates published between 2000 and 2025 was undertaken. Key developments in the management of cervical, ovarian, endometrial, vulvar, and vaginal cancers were critically analysed, with particular focus on prevention strategies, surgical  \nevolution, and integration of targeted and immune therapies.  \nKey Content and Findings: In cervical cancer, population-level human papillomavirus (HPV) vaccination has dramatically reduced incidence, while the LACC and SHAPE trials prompted a return to open and less radical surgery, respectively. Sentinel node biopsy is supplanting systematic lymphadenectomy, and combined chemoradiotherapy (CRT) with immunotherapy is improving survival in locally advanced disease. For ovarian cancer, optimal cytoreduction remains key, with TRUST highlighting surgical quality, while heated intraperitoneal chemotherapy (HIPEC) and poly-ADP ribose polymerase (PARP) inhibitors—alone or combined with immunotherapy—extend progression-free survival (PFS) . Endometrial cancer management is now driven by molecular classification [The Cancer Genome Atlas (TCGA)/Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE)], with immunotherapy and targeted therapy transforming outcomes. In vulvar and vaginal cancers, GROINSS-V (Groin Sentinel Node Trial in Vulvar Cancer) and related studies underpin de-escalated and minimally invasive nodal surgery, while  \nimmunotherapy emerges for advanced disease.  \nConclusions: Modern GO is defined by prevention, precision, and personalisation. The contemporary Gynaecological Oncologist now integrates molecular insight, function-preserving surgery, and  \nmultidisciplinary collaboration to deliver optimised, patient-centred care.  \n^ ORCID: Sabina I","cbCain3IM6CczmJQ","https://ap.wps.com/l/cbCain3IM6CczmJQ","pdf",392922,22,"English","# Background and Objective\n# Methods\n# Key Content and Findings\n## Cervical Cancer\n## Ovarian Cancer\n## Endometrial Cancer\n## Vulvar and Vaginal Cancers\n# Conclusions","[{\"question\":\"What time span and evidence sources does the review cover?\",\"answer\":\"The review is a structured narrative review of landmark publications and guideline updates published between 2000 and 2025.\"},{\"question\":\"How has cervical cancer management changed according to the review?\",\"answer\":\"Population-level HPV vaccination reduced incidence, and trials such as LACC and SHAPE drove a move back toward open and less radical surgery, alongside sentinel node biopsy and improved locally advanced survival with combined chemoradiotherapy plus immunotherapy.\"},{\"question\":\"What overarching model defines modern gynaecological oncology in the conclusions?\",\"answer\":\"Modern gynaecological oncology is defined by prevention, precision, and personalisation, integrating molecular insight, function-preserving surgery, and multidisciplinary collaboration for patient-centred care.\"}]","Precision, prevention and progress: charting two decades of change in gynaecological oncology - a narrative review | PDF",1790120676,55,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6a5e45dc3920f324afb26e226ea93426.webp",983,1287,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c97b602a9a6f843f5338ab67ede82cdc.webp",982,1286,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e0a4fd752f26c918f29262bfba46c7b5.webp",981,1284,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aeba8e3c209dd37a9fe829f2844e2184.webp",980,1283]